Clascoterone and other topical anti-androgens are being studied for male pattern hair loss. Strand is building a dermatologist-supervised pathway for patients who want to understand whether prescription options, clinical trials, or currently available treatments may be appropriate. This is an interest list, not a prescription pathway. Clascoterone is not currently FDA-approved for hair loss.